Johnson & Johnson
JNJ
$271.11
$8.743.33%
NYSE
| 06/28/2026 | 03/29/2026 | 12/28/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 97.93B | 96.36B | 94.19B | 92.15B | 90.63B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 97.93B | 96.36B | 94.19B | 92.15B | 90.63B |
| Cost of Revenue | 31.21B | 30.80B | 30.07B | 29.16B | 28.63B |
| Gross Profit | 66.72B | 65.56B | 64.13B | 62.99B | 62.00B |
| SG&A Expenses | 24.50B | 24.00B | 23.13B | 22.74B | 22.21B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.81B | 69.77B | 67.86B | 67.62B | 67.83B |
| Operating Income | 27.12B | 26.59B | 26.33B | 24.53B | 22.80B |
| Income Before Tax | 25.20B | 24.94B | 32.58B | 31.50B | 27.35B |
| Income Tax Expenses | 4.16B | 3.90B | 5.78B | 6.38B | 4.69B |
| Earnings from Continuing Operations | 21.04K | 21.04K | 26.80K | 25.12K | 22.66K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.04B | 21.04B | 26.80B | 25.12B | 22.66B |
| EBIT | 27.12B | 26.59B | 26.33B | 24.53B | 22.80B |
| EBITDA | 34.87B | 34.33B | 33.84B | 31.92B | 30.25B |
| EPS Basic | 8.71 | 8.71 | 11.11 | 10.42 | 9.40 |
| Normalized Basic EPS | 6.97 | 6.90 | 6.98 | 6.56 | 6.25 |
| EPS Diluted | 8.63 | 8.65 | 11.05 | 10.36 | 9.35 |
| Normalized Diluted EPS | 6.90 | 6.85 | 6.95 | 6.52 | 6.22 |
| Average Basic Shares Outstanding | 9.66B | 9.66B | 9.66B | 9.65B | 9.65B |
| Average Diluted Shares Outstanding | 9.75B | 9.73B | 9.71B | 9.70B | 9.70B |
| Dividend Per Share | 5.24 | 5.20 | 5.14 | 5.08 | 5.02 |
| Payout Ratio | 59.99% | 59.52% | 46.19% | 48.70% | 53.34% |